Grants for Public and State controlled institutions of higher education - Science and Technology

The DoD Kidney Cancer, Clinical Trial Award is a funding opportunity aimed at supporting the implementation of clinical trials that have the potential to significantly impact the treatment or management of kidney cancer, with a focus on new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies.

This initiative provides $52.5 million in cash awards to teams developing innovative technologies for capturing carbon dioxide from the atmosphere, with a focus on promoting environmental equity and community benefits.

This funding opportunity is designed to support citizen science projects that enhance federal fisheries stock assessments and improve understanding of climate change impacts on fish stocks and fishing communities.

With a focus on enhancing research capacity and broadening participation of new faculty of biology at minority-serving institutions (MSIs), predominantly undergraduate institutions (PUIs), and other universities and colleges that are not among the nations most research-intensive institutions, the Directorate for Biological Sciences (BIO) offers theBuilding Research Capacity of New Faculty in Biology(BRC-BIO) program. The BRC-BIO program aims to a) broaden participation by expanding the types of institutions that submit proposals to BIO, and b) expand opportunities to groups underrepresented in the biological sciences, including Blacks and African Americans, Hispanics, Latinos, Native Americans, Alaska Natives, Native Hawaiians and other Pacific Islanders, and persons with disabilities, especially those serving at under-resourced institutions. Awards will provide the means for new faculty to initiate and build independent research programs by enhancing their research capacity. These projects might also include biology-focused research collaborations among faculty within the same institution, across peer-, or research-intensive institutions, or partnerships with industry or other non-academic partners that advance the candidates research program. By providing this funding opportunity, BIO recognizes the national urgency to broaden, strengthen, and diversify the science, technology, engineering, and mathematics (STEM) workforce. In particular, these awards will build capacity for research at institutions that have a primary focus on teaching and undergraduate education, or that have limited capacity for research. Projects should enable the establishment of sustainable research programs for faculty and also enrich undergraduate research experiences and thereby grow the STEM workforce. BRC-BIO welcomes proposals from principal investigators who share NSF's commitment to diversity, equity, and inclusion. Proposals in response to this solicitation must be submitted to the Division of Biological Infrastructure (DBI) in the Directorate for Biological Sciences (BIO).

The Pfizer Sickle Cell Disease (SCD) Fellowship Grant is designed to bolster the number of fellowship programs focused on hematologists who specialize in the treatment of adults with sickle cell disease. This initiative is part of Pfizer Global Medical Grants' broader strategy to support healthcare community-led initiatives that enhance patient outcomes in critical areas of unmet medical need, aligning with Pfizer’s own medical and scientific strategies. The grant aims to enhance the quality of care for sickle cell patients by funding institutions that provide comprehensive training and research opportunities in the field. Specifically, the program supports both established and newly developed fellowship programs that include a robust curriculum in clinical practice, independent research, and education to deepen the scientific understanding of SCD. The fellowship is structured to foster an environment of expert mentorship and significant independent research opportunities. Research activities encouraged under this grant include observational studies and outcomes research that focus on the disease itself, screening tools, and their impact on patient health improvement. Grant funding is set at a maximum of $100,000 for a one-year fellowship, aiming to cover direct costs associated with the fellow’s training and research but explicitly excluding overhead or indirect costs. This financial support underlines Pfizer's commitment to advancing healthcare by investing directly in the development of professionals who are dedicated to improving patient outcomes in the field of sickle cell disease. Key to the grant’s operational framework is compliance with stringent regulatory requirements, including the U.S. Physician Payments Sunshine Act. This act mandates detailed reporting of all transfers of value to ensure transparency and maintain public trust in healthcare practices. The fellowship’s funding structure is designed to be transparent, with specific provisions to prevent any of the funds from benefiting Pfizer's business interests directly or indirectly. Overall, the Pfizer SCD Fellowship embodies a strategic effort to cultivate talent and advance knowledge in a critical area of healthcare, ensuring that the supported programs maintain high standards of integrity and contribute significantly to the field's body of knowledge and patient care practices.

This ISO seeks solution summary and proposal submissions for projects that fall within the scope of the ARPA-H mission Resilient Systems Office (RSO). RSOs interest areas will address systemic challenges across the healthcare and public health landscape by investing in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care.Aspects of todays health and public health systems remain fragile due to systemic challenges, which include rising healthcare costs, inadequate healthcare coverage for significant populations, outdated infrastructure, and health disparities among different demographic groups. Acute challenges, such as hospital closures, supply chain disruptions, staffing shortages, cyber-attacks, public health crises, and the emergence of new diseases, further exacerbate existing fragilities, making it more difficult to maintain high standards of care. These challenges are compounded by the fact that systems remain fragmented, hindering the ability to gain comprehensive insights, make informed decisions, develop tailored interventions, and share critical health information between stakeholders.RSO seeks solution summaries and proposals that drive innovations to enhance the adaptability, reliability, and interoperability of the health ecosystem. Of interest are innovations that foster flexibility and enable adaptation to system stressors, so that people and systems remain well-positioned to deliver high-quality care and improve health outcomes. The following interest areas categorize the ground-breaking research we seek to support:Sociotechnical System Innovation: Innovate user-centric digital health tools, platforms, technologies, and intervention models that improve outcomes across the health continuum, including prevention, diagnosis, and treatment of physical, mental, and behavioral health. Approaches to build trust in the healthcare system and distribute high-quality health guidance in an understandable manner that improves patient outcomes. Novel real-time measurement tools to track health outcomes, evaluate post-market performance of new interventions, and enable convergence on the most effective strategies to improve the quality of care, especially for underserved communities. Other population centered innovations to create more resilient communities and subpopulations. Innovations might include aggregate improvements to quality of care and better physical, mental, and behavioral health outcomes for the health ecosystem.Health Ecosystem Integration: Novel ways to collect, protect, secure, integrate, analyze, communicate, and present health data, including but not limited to advances in privacy, cyber security, artificial intelligence with enhanced patient safety properties, low-code or no-code technologies, semantic approaches, and rapid integration techniques. Strategies and technologies to leverage homes, community centers, pharmacies, and other accessible locations to enable new modalities of high-quality care, expand the reach of clinical research, or integrate end-user feedback to rapidly iterate prototype designs. Approaches to strengthen the connectivity and interoperability of health data and devices to 5 enable the safe, secure, and seamless exchange of information among healthcare providers, researchers, and stakeholders. Other novel approaches to increase the interoperability of health-related systems in support of improved health outcomes and enhanced transparency across the health ecosystem.Adaptive Antifragile Solutions: Creative approaches to enhance the stability and dependability of the health ecosystem through new adaptive paradigms, methods that anticipate and mitigate disruptions before they occur, and enhancements to emergency response. Approaches that enable health infrastructure to rapidly integrate information from new sensors; create decision support tools; adapt supply chains, manufacturing, and logistics; and better leverage the workforce during public health emergencies. Novel methods to engineer resilient tissues, microbiomes, and biophysical systems to combat disease or maintain health. Other novel approaches to enhance adaptability and reduce fragility within the health ecosystem.Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, systems, or methodology. Specifically excluded are proposals that represent an evolutionary or incremental advance in the state of the art or technology that has reached the clinical trial stage. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission

Artificial Intelligence (AI) has advanced tremendously and today promisespersonalizedhealthcare; enhanced national security; improved transportation; and more effective education, to name just a few benefits. Increased computing power, the availability of large datasets and streaming data, and algorithmic advances in machine learning (ML) have made it possible for AI research and development to create new sectors of the economy and revitalize industries. Continued advancement, enabled bysustainedfederal investment and channeled toward issues of national importance, holds the potentialfor further economic impact and quality-of-life improvements. The 2023 update to theNational Artificial Intelligence Research and Development Strategic Plan,informed byvisioning activities in the scientific communityas well asinteraction with the public, identifies as its first strategic objective the need to make long-term investments in AI research in areas with the potential for long-term payoffs in AI. AI Institutes represent a cornerstone Federal Government commitment to fostering long-term, fundamental research in AI while also delivering significantly on each of the other eight objectives in that strategy. The National Security Commission on Artificial Intelligence (NSCAI) identifies AI Institutes as a key component of a bold, sustained federal push to scale and coordinate federal AI R funding and to reinforce the foundation of technical leadership in AI. This program is a multisector effort led by the National Science Foundation (NSF), in partnership with the Simons Foundation (SF), the National Institute of Standards and Technology (NIST), Department of Defense (DOD) Office of the Under Secretary of Defense for Research and Engineering (OUSD (R)), Capital One Financial Corporation (Capital One),and Intel Corporation (Intel). This program solicitation expands the nationwide network of AI Research Institutes with new funding opportunities over the next two years.In this round, the program invites proposals for institutes that have a principal focus in one of the following themes aimed at transformational advances in a range of economic sectors, and science and engineering fields: Group 1 - Awards anticipated in FY 2024: Theme 1: AI for Astronomical Sciences Group 2 - Awards anticipated in FY 2025: Theme 2: AI for Discovery in Materials Research Theme 3: Strengthening AI For the institute themes listed in Group 1, NSF anticipates awards to start in FY 2024; and forthemes listed in Group 2, NSF anticipates awards to start in FY 2025. Each group has a specific set of due dates and review timeline pertaining only to that group. Moredetail is found under Due Dates and in the timeline provided in the Program Description.

The MMRDA mechanism is intended to fund the logical continuation of previously DOD-funded research or development efforts relevant to the above FY24 JWMRP Focus Areas with the highest potential to augment and accelerate medical product development and health care solutions for active-duty Service Members, their Families, Veterans, and/or the American public. Collaboration with DOD organizations is encouraged when this alliance would contribute to the success of the research effort, and any funds designated for DOD laboratories or activities should be identified in the application/proposal through submission of a Suggested Intragovernmental/Intramural Budget Form, Attachment 15. Applications/proposals from small businesses and/or partnerships with industry are also encouraged. The MMRDA mechanism supports a wide range of research projects, spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, and translational research. A Clinical Research or Clinical Trial Option is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices, and technologies. Note: Applications/proposals submitted under this option will be required to submit additional relevant application/proposal materials.

This Funding Opportunity Announcement (FOA) describes a newly proposed initiative of the Air Force Research Laboratory (AFRL) concerning standing up a University Center of Excellence (CoE) for Data Assimilation (DA) Driven by Mathematical Features Representing Physics with educational institutions in the United States. The University CoE is defined as a joint effort among multiple technical directorates (TDs) of the Air Force Research Laboratory to include: the Air Force Office of Scientific Research (AFOSR), Aerospace Systems Directorate (RQ), Space Vehicles Directorate (RV), and Munitions Directorate (RW), referred to collectively as we, our, or us, in this FOA, and an outstanding university or team of universities that will perform high priority unclassified and collaborative basic / applied (6.1/ 6.2) research which addresses the United States Air Force (USAF) and United States Space Force (USSF) research needs in the DA area with relevance to high-speed flows and combustion.

This funding opportunity provides financial support for innovative breast cancer research projects aimed at preventing the disease, understanding its recurrence, or improving treatment, targeting both early-stage and more developed studies from a range of eligible organizations and researchers.

**AMENDED on DECEMBER 11 2023**: The latest revision is posted as Amendment 18. Potential applicants are strongly encouraged to review the Amendment in its entirety, as it updates several sections. Specifically, ATTACHMENT 1: SPECIFIC TOPICS now includes Basic Research Topics N1-N4, with white papers due by 11:59pm EST on 5 February 2024. White papers may not be considered if they are received after this deadline. In addition, submissions to the general thrust areas in accordance with the requirements detailed in the BAA are also welcome. ** Please note that all correspondence must be sent to the appropriate Agency contact identified in Section 7. Agency Contacts. **

This grant provides funding for collaborative clinical trials aimed at improving the diagnosis and treatment of health issues related to military toxic exposures, targeting researchers and institutions involved in this critical area of study.

**CYCLE 4 POSTED ON 10 APRIL 2024. SEE ATTACHED UPDATED ANNOUNCEMENT FOR SPECIFIC TOPICS OF INTEREST IN CYCLE 4 AND SUBMISSION INFORMATION** **CYCLE 3, ORIGINALLY POSTED ON 21 MARCH 2023, IS UPDATED TO INCLUDE A QUESTION AND ANSWER DOCUMENT AND TO UPDATE THE SUBMISSION DATE TO 5 MAY 2023 BY 1700 EASTERN TIME** **CYCLE 3 POSTED ON 21 MARCH 2023. SEE ATTACHED UPDATED ANNOUNCEMENT FOR SPECIFIC TOPICS OF INTEREST IN CYCLE 3 AND SUBMISSION INFORMATION** **CYCLE 2 POSTED ON 8 FEBRUARY 2021. SEE ATTACHED UPDATED ANNOUNCEMENT FOR SPECIFIC TOPICS OF INTEREST IN CYCLE 2 AND SUBMISSION INFORMATION** Purpose: Future Army forces will need to conduct cross-domain maneuver (CDM) and at times, operate semi-independently, disbursed, and while communications and infrastructure such as Global Positioning System (GPS) are disrupted or denied. Robotics and Autonomous Systems (RAS) will play a key role in expanding the operational reach, situational awareness, and effectiveness of maneuver forces in CDM. The Combat Capabilities Development Command (CCDC) Army Research Laboratory (ARL) is focused on developing fundamental understanding and informing the art-of-the-possible for warfighter concepts through research to greatly improve air and ground based autonomous vehicle perception, learning, reasoning, communication, navigation, and physical capabilities to augment and increase the freedom of maneuver in complex and contested environments. The Scalable, Adaptive, and Resilient Autonomy (SARA) program is focused on developing and experimentally accelerating emerging research in autonomous mobility and maneuverability, scalable heterogeneous and collaborative behaviors, and human agent teaming to realize adaptive and resilient Intelligent Systems that can reason about the environment, work in distributed and collaborative heterogeneous teams, and make op-tempo decisions to enable Autonomous Maneuver in complex and contested environments. In order to achieve this vision, advancements are needed in following: Novel methods for all-terrain ground and aerial maneuver to interact with and move through complex environments. Methods for scalable and heterogeneous collaborative behaviors in support of collaborative air and ground manned-unmanned teaming operations. Techniques for improved perception, decision-making, and adaptive behaviors for fully autonomous maneuver in contested environments. Methods, metrics, and tools to facilitate, simulate, and enable testing and evaluation of emerging approaches for intelligent and autonomous systems under Army relevant constraints and environments Experimental testbeds to develop and refine knowledge products to inform and transition technology to Army stakeholders.

This funding opportunity supports a wide range of organizations in developing advanced component technologies that are essential for NASA's space and Earth science missions.

This funding opportunity provides financial support to U.S.-based non-profit organizations and academic institutions to help improve weather and climate forecasting capabilities in developing countries, ultimately enhancing their disaster risk reduction efforts.

This grant provides funding for non-profits, educational institutions, and government organizations to implement programs that promote understanding of emerging technologies, enhance English teacher training, strengthen U.S. alumni networks, and celebrate 30 years of U.S.-Vietnam relations.

This funding opportunity provides financial support to various organizations and institutions to help prevent adversaries from exploiting advanced technologies and commercial facilities for military purposes, focusing on enhancing global partnerships and security measures.

This funding opportunity provides financial support to organizations that will help laboratories in Latin America improve their capabilities in analyzing genome sequences to investigate potential biological weapons attacks.

This funding opportunity supports late-stage preclinical studies using adult stem cells to advance regenerative medicine therapies, specifically for researchers who have previously received NIH funding in this area.

The Projects for Organizations grant opportunity, offered by the Idaho Commission on the Arts, aims to support public projects and events by nonprofit organizations, informal arts groups applying through fiscal agents, and arts-in-education projects within schools and school districts. This grant aligns with the Commission's mission to foster arts and culture within Idaho by directly funding initiatives that engage the public and promote arts education. The program specifically targets organizations operating in Idaho for at least one year with a valid 501(c)(3) status or governmental units including schools. The primary beneficiaries of this grant are the citizens of Idaho, who benefit from increased access to public arts projects and events, and students within the state, who gain from enhanced arts-in-education programming. The impact goals include enriching community life through cultural offerings and fostering artistic development and appreciation. The grant prioritizes projects that compensate professional artists and meet specific eligibility criteria, ensuring a high standard of artistic endeavor and professional practice. Funding information indicates that grants are up to $1,100 and require a 1:1 match (cash or in-kind), funding up to 50% of projected expenses. This demonstrates a strategic priority to leverage additional resources and encourage community investment in arts projects. While specific measurable results beyond successful project completion and financial accountability are not explicitly detailed, the focus on public projects and arts-in-education implies expected outcomes such as increased community engagement in the arts and improved arts literacy among students. The Idaho Commission on the Arts' strategic priority, as reflected in this grant, is to provide accessible funding for a diverse range of artistic and cultural projects across all counties in Idaho. Their theory of change appears to be that by providing financial support and setting clear eligibility and project guidelines, they can empower local organizations and schools to deliver high-quality arts experiences, thereby enriching communities and fostering a vibrant arts ecosystem throughout the state. The requirement for final reports for past grants also indicates a commitment to accountability and continuous improvement within their funding programs.